MetLife Investment Advisors »

Amneal Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $418k 69k 6.07
2023-09-30 $290k 69k 4.22
2023-06-30 $213k 69k 3.10
2023-03-31 $39k 28k 1.39
2022-12-31 $93k 47k 1.99
2022-09-30 $113k 56k 2.02
2022-06-30 $93k 29k 3.18
2022-03-31 $243k 58k 4.17
2021-12-31 $104k 22k 4.79
2021-09-30 $216k 40k 5.35
2021-06-30 $207k 40k 5.12
2021-03-31 $272k 40k 6.73
2020-12-31 $96k 21k 4.57
2020-09-30 $135k 35k 3.88
2020-06-30 $263k 55k 4.76
2020-03-31 $192k 55k 3.47
2019-12-31 $266k 55k 4.81
2019-09-30 $118k 41k 2.91
2019-06-30 $291k 41k 7.18
2019-03-31 $574k 41k 14.16
2018-12-31 $548k 41k 13.52
2018-09-30 $1.4M 63k 22.20